{"id":179895,"date":"2018-09-03T06:32:41","date_gmt":"2018-09-03T10:32:41","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=179895"},"modified":"2018-09-03T06:32:41","modified_gmt":"2018-09-03T10:32:41","slug":"aussie-researchers-develop-device-warn-impending-heart-attack","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2018\/09\/03\/aussie-researchers-develop-device-warn-impending-heart-attack\/","title":{"rendered":"Aussie researchers develop device to warn of impending heart attack"},"content":{"rendered":"<figure id=\"attachment_179896\" aria-describedby=\"caption-attachment-179896\" style=\"width: 640px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2018\/09\/4952166117_a1683a1242_z.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-179896\" src=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2018\/09\/4952166117_a1683a1242_z.jpg\" alt=\"\" width=\"640\" height=\"469\" srcset=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2018\/09\/4952166117_a1683a1242_z.jpg 640w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2018\/09\/4952166117_a1683a1242_z-300x220.jpg 300w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/a><figcaption id=\"caption-attachment-179896\" class=\"wp-caption-text\">&#8220;It&#8217;s a personalized approach,&#8221; fellow team leader Elizabeth Gardiner told the Australian Broadcasting Corporation (ABC). (File <a href=\"https:\/\/www.flickr.com\/photos\/jasleen_kaur\/4952166117\/\">Photo<\/a>: <a href=\"https:\/\/www.flickr.com\/photos\/jasleen_kaur\/\">Jasleen Kaur\/Flickr<\/a>,<a href=\"https:\/\/creativecommons.org\/licenses\/by-sa\/2.0\/\"> CC BY-SA 2.0<\/a>)<\/figcaption><\/figure>\n<p><strong>CANBERRA<\/strong>\u00a0&#8212; Australian National University (ANU) researchers have developed a bio-optics diagnostic device that can help prevent heart attacks and stroke, according to the researchers.<\/p>\n<p>The device can identify imminent and dangerous blood clots before they form, potentially saving patients from experiencing a stroke or heart attack.<\/p>\n<p>Using a sample of a patient&#8217;s blood, the device provides a 3D map of how the patient&#8217;s platelets react when damaged.<\/p>\n<p>Steve Lee, the team leader on the project, said the map provided medical practitioners with a profile of how a patient&#8217;s platelets react when they are at risk of developing a blood clot.<\/p>\n<p>&#8220;Using the new diagnostic device that our team has developed, we can create and quantify clot formation in a 3D view from a blood sample without any form of labelings such as fluorescence or radiotracer &#8212; this had been impossible to achieve until now,&#8221; he said in a media release on Wednesday.<\/p>\n<p>The diagnostic device creates the map by measuring the time it takes for light to travel through damaged platelets.<\/p>\n<p>Researchers believe the technology will revolutionize how doctors treat blood clots.<br \/>\nThe current approach for doctors treating clots is to prescribe a common blood thinner.<\/p>\n<p>However, the new device will allow a doctor to assess a patient&#8217;s risk of heart attack or stroke with precision for the first time and undertake tailored treatment.<\/p>\n<p>&#8220;It&#8217;s a personalized approach,&#8221; fellow team leader Elizabeth Gardiner told the Australian Broadcasting Corporation (ABC).<\/p>\n<p>&#8220;There are clear differences in how people respond to a standard injury and&#8230; now we need to evaluate specific patient types.&#8221;<\/p>\n<p>&#8220;I would imagine we would be able to reduce the amount of medication.&#8221;<\/p>\n<p>The method is not yet suitable for regular use in hospitals but the ANU team is optimistic that it will become commonplace within two years.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CANBERRA\u00a0&#8212; Australian National University (ANU) researchers have developed a bio-optics diagnostic device that can help prevent heart attacks and stroke, &hellip;<\/p>\n","protected":false},"author":44,"featured_media":179896,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[],"class_list":["post-179895","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","mauthors-xinhuanet","mauthors-philippine-news-agency"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/179895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=179895"}],"version-history":[{"count":0,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/179895\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/179896"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=179895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=179895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=179895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}